|Articles|March 1, 2020
- Pharmaceutical Executive-03-01-2020
- Volume 40
- Issue 3
Pharmaceutical Executive, March 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
The Multichannel Reach: Balancing the Local and Global Voiceabout 6 years ago
Market Access: From Being to Becomingabout 6 years ago
Consider Data Before It’s a Problemabout 6 years ago
Multichannel Marketing: Integrating Omnichannelover 6 years ago
Feds Target Biosimilar Anticompetitive Practicesover 6 years ago
Blood Feud Divides Europe Over Plasma Shortfallsover 6 years ago
Social Media’s Influence in Messaging Mixover 6 years ago
Habib Bennaceur: Following the Scienceover 6 years ago
A Bad Deal with Data?over 6 years ago
Country Report: United Arab EmiratesAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
2
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
3
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
4
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
5